These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 26348884
1. In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage. Kumar H, Frischknecht F, Mair GR, Gomes J. Infect Genet Evol; 2015 Dec; 36():72-81. PubMed ID: 26348884 [Abstract] [Full Text] [Related]
2. Genetic engineering of attenuated malaria parasites for vaccination. Khan SM, Janse CJ, Kappe SH, Mikolajczak SA. Curr Opin Biotechnol; 2012 Dec; 23(6):908-16. PubMed ID: 22560204 [Abstract] [Full Text] [Related]
3. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine. Kreutzfeld O, Müller K, Matuschewski K. Front Cell Infect Microbiol; 2017 Dec; 7():198. PubMed ID: 28620583 [Abstract] [Full Text] [Related]
4. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH. J Infect Dis; 2007 Aug 15; 196(4):608-16. PubMed ID: 17624848 [Abstract] [Full Text] [Related]
5. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine. Nagel A, Prado M, Heitmann A, Tartz S, Jacobs T, Deschermeier C, Helm S, Stanway R, Heussler V. Int J Parasitol; 2013 May 15; 43(6):503-14. PubMed ID: 23500072 [Abstract] [Full Text] [Related]
6. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Mueller AK, Labaied M, Kappe SH, Matuschewski K. Nature; 2005 Jan 13; 433(7022):164-7. PubMed ID: 15580261 [Abstract] [Full Text] [Related]
7. New pieces for the malaria liver stage puzzle: where will they fit? Mota MM, Rodriguez A. Cell Host Microbe; 2008 Feb 14; 3(2):63-5. PubMed ID: 18312840 [Abstract] [Full Text] [Related]
8. Vaccination using radiation- or genetically attenuated live sporozoites. Vaughan AM, Kappe SH. Methods Mol Biol; 2013 Feb 14; 923():549-66. PubMed ID: 22990804 [Abstract] [Full Text] [Related]
9. Protective immunity against malaria liver stage after vaccination with live parasites. Rénia L. Parasite; 2008 Sep 14; 15(3):379-83. PubMed ID: 18814710 [Abstract] [Full Text] [Related]
10. Malaria--there could be a third way. Miles MA. Nature; 2003 Jan 02; 421(6918):13. PubMed ID: 12511928 [No Abstract] [Full Text] [Related]
11. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Aly AS, Downie MJ, Mamoun CB, Kappe SH. Cell Microbiol; 2010 Jul 02; 12(7):930-8. PubMed ID: 20088947 [Abstract] [Full Text] [Related]
12. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. Putrianti ED, Silvie O, Kordes M, Borrmann S, Matuschewski K. J Infect Dis; 2009 Mar 15; 199(6):899-903. PubMed ID: 19434915 [Abstract] [Full Text] [Related]
13. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development. Inoue M, Tang J, Miyakoda M, Kaneko O, Yui K, Culleton R. Int J Parasitol; 2012 Aug 15; 42(9):859-70. PubMed ID: 22846785 [Abstract] [Full Text] [Related]
14. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. Annoura T, Ploemen IH, van Schaijk BC, Sajid M, Vos MW, van Gemert GJ, Chevalley-Maurel S, Franke-Fayard BM, Hermsen CC, Gego A, Franetich JF, Mazier D, Hoffman SL, Janse CJ, Sauerwein RW, Khan SM. Vaccine; 2012 Mar 30; 30(16):2662-70. PubMed ID: 22342550 [Abstract] [Full Text] [Related]
15. Time for Genome Editing: Next-Generation Attenuated Malaria Parasites. Singer M, Frischknecht F. Trends Parasitol; 2017 Mar 30; 33(3):202-213. PubMed ID: 27793562 [Abstract] [Full Text] [Related]
17. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Spring M, Murphy J, Nielsen R, Dowler M, Bennett JW, Zarling S, Williams J, de la Vega P, Ware L, Komisar J, Polhemus M, Richie TL, Epstein J, Tamminga C, Chuang I, Richie N, O'Neil M, Heppner DG, Healer J, O'Neill M, Smithers H, Finney OC, Mikolajczak SA, Wang R, Cowman A, Ockenhouse C, Krzych U, Kappe SH. Vaccine; 2013 Oct 09; 31(43):4975-83. PubMed ID: 24029408 [Abstract] [Full Text] [Related]
18. Arrest in the liver--a genetically defined malaria vaccine? Frevert U, Nardin E. N Engl J Med; 2005 Apr 14; 352(15):1600-2. PubMed ID: 15829544 [No Abstract] [Full Text] [Related]
19. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites. van Schaijk BC, Ploemen IH, Annoura T, Vos MW, Foquet L, van Gemert GJ, Chevalley-Maurel S, van de Vegte-Bolmer M, Sajid M, Franetich JF, Lorthiois A, Leroux-Roels G, Meuleman P, Hermsen CC, Mazier D, Hoffman SL, Janse CJ, Khan SM, Sauerwein RW. Elife; 2014 Nov 19; 3():. PubMed ID: 25407681 [Abstract] [Full Text] [Related]
20. Molecular Markers of Radiation Induced Attenuation in Intrahepatic Plasmodium falciparum Parasites. Oakley MS, Verma N, Zheng H, Anantharaman V, Takeda K, Gao Y, Myers TG, Pham PT, Mahajan B, Kumar N, Sangweme D, Tripathi AK, Mlambo G, Aravind L, Kumar S. PLoS One; 2016 Nov 19; 11(12):e0166814. PubMed ID: 27911910 [Abstract] [Full Text] [Related] Page: [Next] [New Search]